SG10201402723QA - Flavonoid hydrogel - Google Patents
Flavonoid hydrogelInfo
- Publication number
- SG10201402723QA SG10201402723QA SG10201402723QA SG10201402723QA SG10201402723QA SG 10201402723Q A SG10201402723Q A SG 10201402723QA SG 10201402723Q A SG10201402723Q A SG 10201402723QA SG 10201402723Q A SG10201402723Q A SG 10201402723QA SG 10201402723Q A SG10201402723Q A SG 10201402723QA
- Authority
- SG
- Singapore
- Prior art keywords
- flavonoid
- hydrogel
- flavonoid hydrogel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/738—Cross-linked polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6903—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being semi-solid, e.g. an ointment, a gel, a hydrogel or a solidifying gel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2397/00—Characterised by the use of lignin-containing materials
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Polymers & Plastics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Obesity (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21333109P | 2009-05-29 | 2009-05-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201402723QA true SG10201402723QA (en) | 2014-10-30 |
Family
ID=43222961
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201402723QA SG10201402723QA (en) | 2009-05-29 | 2010-05-17 | Flavonoid hydrogel |
SG2011088283A SG176286A1 (en) | 2009-05-29 | 2010-05-17 | Flavonoid hydrogel |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2011088283A SG176286A1 (en) | 2009-05-29 | 2010-05-17 | Flavonoid hydrogel |
Country Status (5)
Country | Link |
---|---|
US (3) | US8541016B2 (en) |
EP (1) | EP2435504B1 (en) |
JP (2) | JP5843758B2 (en) |
SG (2) | SG10201402723QA (en) |
WO (1) | WO2010138082A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2214715B1 (en) * | 2007-10-23 | 2018-04-18 | Agency For Science, Technology And Research | Method of delivering an anti-cancer agent to a cell |
US8734867B2 (en) | 2007-12-28 | 2014-05-27 | Liveleaf, Inc. | Antibacterial having an extract of pomegranate combined with hydrogen peroxide |
EP2435504B1 (en) | 2009-05-29 | 2020-03-11 | Agency For Science, Technology And Research | Flavonoid hydrogel |
EP2544768A4 (en) * | 2010-03-11 | 2016-02-24 | Agency Science Tech & Res | Anti-cancer agent delivery vehicles capable of improved laoding |
US9192635B2 (en) | 2011-06-24 | 2015-11-24 | Liveleaf, Inc. | Method of treating damaged mucosal or gastrointestinal tissue by administering a composition comprising a mixture of pomegranate and green tea extracts and releasably bound hydrogen peroxide |
US8722040B2 (en) * | 2011-06-24 | 2014-05-13 | Liveleaf, Inc. | Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites |
US8716351B1 (en) | 2012-12-23 | 2014-05-06 | Liveleaf, Inc. | Methods of treating gastrointestinal spasms |
EP3011016B1 (en) * | 2013-06-18 | 2019-08-07 | Agency For Science, Technology And Research | Method of culturing cancer stem cells |
EP3041830B1 (en) * | 2013-09-03 | 2023-10-25 | Agency For Science, Technology And Research | Polymer-flavonoid conjugates and hydrogels for biomedical applications |
GB2518405A (en) * | 2013-09-20 | 2015-03-25 | Zeiss Carl Meditec Ag | Composition comprising at least one viscoelastic polymer |
WO2015070100A1 (en) | 2013-11-08 | 2015-05-14 | The Johns Hopkins University | Oxygen-controllable and hypoxia-inducible hydrogels |
US10004586B2 (en) | 2014-08-27 | 2018-06-26 | The Cleveland Clinic Foundation | Biocompatible tissue graft |
US12077645B2 (en) * | 2018-04-02 | 2024-09-03 | Optipharm Co., Ltd | Alginate microcapsules for cell encapsulation and, manufacturing method therefor |
KR102326127B1 (en) * | 2019-06-27 | 2021-11-12 | 서울대학교산학협력단 | Development of injectable tissue adhesive hydrogel based on polyphenol and its application |
EP4069303A4 (en) * | 2019-12-03 | 2023-11-29 | The Schepens Eye Research Institute, Inc. | Injectable hydrogels for cell delivery to the vitreous |
CN113892643A (en) * | 2021-09-23 | 2022-01-07 | 西北农林科技大学 | Manufacturing method of edible sodium alginate/gelatin 3D gel scaffold adopting tea polyphenol coating and used for cell culture meat |
CN114736254B (en) * | 2022-03-30 | 2024-01-05 | 湖南大学 | Natural flavonoid derivative medicine and preparation method and application thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6630457B1 (en) | 1998-09-18 | 2003-10-07 | Orthogene Llc | Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same |
US6982298B2 (en) | 2003-01-10 | 2006-01-03 | The Cleveland Clinic Foundation | Hydroxyphenyl cross-linked macromolecular network and applications thereof |
US7858080B2 (en) | 2005-05-20 | 2010-12-28 | Agency For Science, Technology And Research | Aldehyde conjugated flavonoid preparations |
CN101180319B (en) * | 2005-05-20 | 2012-06-27 | 新加坡科技研究局 | Aldehyde conjugated flavonoid preparations |
JP4712505B2 (en) * | 2005-09-30 | 2011-06-29 | 富士フイルム株式会社 | Electronic endoscope device |
EP1988938A4 (en) | 2006-02-27 | 2011-09-28 | Agency Science Tech & Res | Curable bone cement |
JP2007297360A (en) * | 2006-05-08 | 2007-11-15 | Ihara Suisan Kk | Hydrogel, production method thereof and use thereof |
JP4308230B2 (en) * | 2006-07-21 | 2009-08-05 | 花王株式会社 | Method for inhibiting catechin coloring |
US20100008869A1 (en) * | 2006-07-21 | 2010-01-14 | Kao Corporation | Method for preventing coloration of catechins and dentifrice composition |
KR100968591B1 (en) * | 2007-06-14 | 2010-07-08 | 한국과학기술연구원 | Polyorganophosphazene hydrogels for drug delivery, preparation method thereof and use thereof |
EP2214715B1 (en) * | 2007-10-23 | 2018-04-18 | Agency For Science, Technology And Research | Method of delivering an anti-cancer agent to a cell |
WO2009148405A1 (en) | 2008-06-05 | 2009-12-10 | Agency For Science, Technology And Research | Formation of hydrogel in the presence of peroxidase and low concentration of hydrogen peroxide |
US8287906B2 (en) | 2008-05-06 | 2012-10-16 | Agency For Science, Technology And Research | Formation of hydrogel in the presence of peroxidase and low concentration of hydrogen peroxide |
EP2435504B1 (en) | 2009-05-29 | 2020-03-11 | Agency For Science, Technology And Research | Flavonoid hydrogel |
EP2544768A4 (en) | 2010-03-11 | 2016-02-24 | Agency Science Tech & Res | Anti-cancer agent delivery vehicles capable of improved laoding |
-
2010
- 2010-05-17 EP EP10780897.4A patent/EP2435504B1/en active Active
- 2010-05-17 SG SG10201402723QA patent/SG10201402723QA/en unknown
- 2010-05-17 SG SG2011088283A patent/SG176286A1/en unknown
- 2010-05-17 US US13/375,097 patent/US8541016B2/en active Active
- 2010-05-17 WO PCT/SG2010/000185 patent/WO2010138082A1/en active Application Filing
- 2010-05-17 JP JP2012513017A patent/JP5843758B2/en not_active Expired - Fee Related
-
2013
- 2013-08-19 US US13/970,432 patent/US9034364B2/en not_active Expired - Fee Related
-
2015
- 2015-04-27 US US14/697,565 patent/US9439886B2/en not_active Expired - Fee Related
- 2015-07-16 JP JP2015141987A patent/JP6112576B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP2435504A4 (en) | 2015-12-02 |
US8541016B2 (en) | 2013-09-24 |
JP6112576B2 (en) | 2017-04-12 |
JP2016014025A (en) | 2016-01-28 |
JP2012528150A (en) | 2012-11-12 |
WO2010138082A1 (en) | 2010-12-02 |
SG176286A1 (en) | 2012-01-30 |
US20130338101A1 (en) | 2013-12-19 |
EP2435504B1 (en) | 2020-03-11 |
JP5843758B2 (en) | 2016-01-13 |
US20150313869A1 (en) | 2015-11-05 |
EP2435504A1 (en) | 2012-04-04 |
US9034364B2 (en) | 2015-05-19 |
US20120070433A1 (en) | 2012-03-22 |
US9439886B2 (en) | 2016-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10201402723QA (en) | Flavonoid hydrogel | |
DK3023438T3 (en) | Anti-gitr-antistoffer | |
DK2457337T3 (en) | Specialtilpasset impuls-burst | |
EP2462514A4 (en) | Greenbooks | |
EP2515891A4 (en) | 3-keto-n-propargyl-1-aminoindan | |
EP2438115A4 (en) | Immuno-compatible hydrogel system | |
HK1146920A1 (en) | Scissor | |
EP2519921A4 (en) | Call-tracking | |
DK2464943T3 (en) | Systemintegration | |
GB0900568D0 (en) | Poymerisation | |
GB0900319D0 (en) | Hydrocharger | |
EP2510125A4 (en) | Hyperprimers | |
AU4925P (en) | Bonscawi Scaevola aemula | |
AU4926P (en) | Bonscalib Scaevola aemula | |
AU4924P (en) | Bonscablue Scaevola aemula | |
AU4240P (en) | Tuckerbox xTriticosecale | |
GB0916459D0 (en) | Concept 36a | |
GB0903349D0 (en) | Concept four | |
EG26256A (en) | Oxyga | |
HU0900041D0 (en) | Crinoline | |
GB0901126D0 (en) | Eco-frame | |
GB0900674D0 (en) | Concrete-shifter | |
GB0900395D0 (en) | Kelpipe | |
GB0900367D0 (en) | Shelta | |
GB0900362D0 (en) | Hipestone |